Expert Opinion on Pharmacotherapy, Volume 24, Issue 7 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Pharmacotherapy, Volume 24, Issue 7 (2023)

See all volumes and issues
Vol 25, 2024 Volume 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Editorial

Editorial
What value do cell cycle inhibitors have in the treatment of myelodysplastic syndrome?
Maria Siddiqui & Gautam Borthakur
Pages: 775-778
Published online: 23 Apr 2023
First Page PreviewforWhat value do cell cycle inhibitors have in the treatment of myelodysplastic syndrome? | Full Text | References | PDF (192.5 KB) | EPUB
  • 658 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Article
The future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for cholangiocarcinoma
Samantha M. Ruff, Sameek Roychowdhury & Timothy M. Pawlik
Pages: 779-788
Published online: 14 Apr 2023
AbstractforThe future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for cholangiocarcinoma | Full Text | References | PDF (2 MB) | EPUB
  • 350 Views
  • 1 CrossRef citations
  • 0Altmetric

Pharmacoeconomic Evaluation

Article
Pharmacoeconomics of novel pharmacotherapies in triple-negative breast cancer
Luca Boscolo Bielo, Dario Trapani & Giuseppe Curigliano
Pages: 789-801
Published online: 11 Apr 2023
AbstractforPharmacoeconomics of novel pharmacotherapies in triple-negative breast cancer | Full Text | References | PDF (377.3 KB) | EPUB
  • 2044 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review
An evaluation of the available pharmacotherapy for the treatment of hirsutism
Leila Asfour, Ahmed Kazmi & Rodney Sinclair
Pages: 803-813
Published online: 03 Apr 2023
AbstractforAn evaluation of the available pharmacotherapy for the treatment of hirsutism | Full Text | References | PDF (477.8 KB) | EPUB
  • 107 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Pharmacological management of systemic sclerosis associated interstitial lung disease
Giles Dixon, Ibrahim Adamali, Huzaifa Adamali, Shaney Barratt, Harsha Gunarwardena & John D. Pauling
Pages: 815-824
Published online: 13 Apr 2023
AbstractforPharmacological management of systemic sclerosis associated interstitial lung disease | Full Text | References | PDF (1,023.5 KB) | EPUB
  • 265 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Advances in the pharmacotherapeutic management of refractory peptic ulcers
Cristina Borao Laguna & Angel Lanas
Pages: 825-833
Published online: 11 Apr 2023
AbstractforAdvances in the pharmacotherapeutic management of refractory peptic ulcers | Full Text | References | PDF (1.2 MB) | EPUB
  • 258 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Peter J. Castagna, Elita Farahdel, Marc N. Potenza & Michael J. Crowley
Pages: 835-847
Published online: 19 Apr 2023
AbstractforThe current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder | Full Text | References | PDF (357.1 KB) | EPUB
  • 247 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors
Alexander Goetsch, Ferdinando D’Amico, Mariangela Allocca, Gionata Fiorino, Federica Furfaro, Alessandra Zilli, Tommaso Lorenzo Parigi, Simona Radice, Laurent Peyrin-Biroulet & Silvio Danese
Pages: 849-861
Published online: 11 Apr 2023
AbstractforAdvances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors | Full Text | References | PDF (2.2 MB) | EPUB
  • 2424 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review
The role of istradefylline in the Parkinson’s disease armamentarium
Thomas Müller
Pages: 863-871
Published online: 18 Apr 2023
AbstractforThe role of istradefylline in the Parkinson’s disease armamentarium | Full Text | References | PDF (678.9 KB) | EPUB
  • 179 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Reply to: intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis
Fiammetta Vanoli & Renato Mantegazza
Page: 873
Published online: 19 Apr 2023
CitationforReply to: intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis | Full Text | References | PDF (128.4 KB) | EPUB
  • 776 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Upadacitinib in Crohn’s disease: needs more insight
Avinash Tiwari
Letter to the Editor | Published online: 17 Jun 2024
Free Access
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement
Rossella Laitano et al.
Review Article | Published online: 16 Jun 2024
The effects of prenatal exposure to opioids on early childhood development: context matters most
Ginny Carter et al.
Review Article | Published online: 13 Jun 2024
Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome
Olga Biniszewska et al.
Review Article | Published online: 13 Jun 2024
View all latest articles